Back to 
BNP PARIBAS FINANCIAL MARKETS
BNP PARIBAS FINANCIAL MARKETS
ALPNShowing 0 of 13 quarters
Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in ALPINE IMMUNE SCIENCES INC
As of its Q1 2024 13F, BNP Paribas Financial Markets held 77,784 shares of ALPN (Alpine Immune Sciences), worth $3.1M. BNP Paribas Financial Markets' 13F filings listed ALPN from Q2 2021 to Q1 2024, 12 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ALPN: Avoro Capital Advisors LLC, BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P.